NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Dennis, I still hope that at some time they may be able to obtain patient level data in the future, perhaps from the GBM agile program.

But at least for now FDA requires patient level data for comparison

I dont think that is going to happen because companies such as NovoCure that should then be delivering their IPD will not be indirectly assisting NWBO in the demise of their device Optune. As I said, I think NWBO will never request approval in the US, but the company buying NWBO will launch a new trial based on tumor shrinkage.